Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06517108
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
Chuna Manual Treatment for Patients With Primary Dysmenorrhea Primary Dysmenorrhea
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Efficacy and Safety of Chuna Manual Treatment for Patients With Primary Dysmenorrhea A Randomized Controlled Trial
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a randomized controlled trial that compares 30 patients with primary dysmenorrhea by assigning them in a 11 ratio between patients treated with a Chuna therapy strategy and patients treated with a strategy using physical therapy The purpose of the study is to confirm the comparative effectiveness of Chuna therapy and physical therapy
Detailed Description:
Menstrual pain is known to be caused by increased tension in the uterine muscles and irregular contractions and is experienced by 50 of women who menstruate However most people control pain with NSAIDs or hormones Among non-pharmacological treatments manual therapy is known to control menstrual pain by influencing pain perception and pain-related serological factors Previous research results have shown that manual therapy using sacroiliac joint correction and high-speed low-amplitude thrust techniques is effective for menstrual pain However there is still no randomized controlled study limited to Chuna therapy Therefore the investigators would like to conduct a randomized clinical study to determine the effectiveness and safety of Chuna therapy for primary dysmenorrhea
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None